PATENT CLAIM ANALYSIS

Application Number: 15944193
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["424", "158100"]

Abstract:
The present invention provides a therapeutic composition for prevention or treatment of neurodegenerative brain disease caused by traumatic brain injury, comprising a regulator increasing expression or activity of calcineurin, and a screening method for a therapeutic agent for traumatic brain injury and neurodegenerative brain disease mediated by tau protein.

Claim (Index 6):
The method of  claim 2 , wherein the PPP3CA or PP2B inhibits phosphorylation or aggregation of Tau protein.

Metadata:
- Claim Count in Document: 38.0
- Percentile: 91.0
- Lexical Diversity: 1.52941
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['15503636', '14776924', '14324289', '10625986', '15424444']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7183125830861217
- 35 USC 102 Novelty (BERT): 0.5334766026760952
- Combined Prediction Score: 0.699828985045119
- Mean Citation Score: 292.59764600000005
- Max Citation Score: 332.16476
- Similarity Product: 217.0023623581147

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test